AstraZeneca PLC Ordinary Shares (AZN)
EBITDA
$20.69B
TTM · Period ending: · USD
AZN EBITDA
Latest reported$20.69Bperiod ending
Latest reported$20.69Bperiod ending
AZN TTM EBITDA ($1.14B → $20.69B)
TTM EBITDA
High-resolution chart · PNG
AZN ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| 4,933,116,885 | |
| 5,020,285,149 | |
| 4,910,980,999 | |
| 3,035,833,991 | |
| 3,017,780,458 | |
| 3,046,925,202 | |
| 6,374,965,058 | |
| 1,541,716,666 | |
| 2,702,916,666 | |
| 2,302,916,666 | |
| 198,916,666 | |
| 1,206,352,940 | |
| 975,552,940 | |
| 2,390,552,940 | |
| 2,257,052,940 | |
| 3,819,592,394 | |
| 4,033,792,394 | |
| 4,028,292,394 | |
| 4,022,792,394 | |
| 2,117,990,006 | |
| 1,739,390,006 | |
| -160,409,994 | |
| -421,809,994 | |
| 300,938,421 | |
| 118,738,421 | |
| 1,576,838,421 | |
| 1,396,538,421 | |
| 1,531,385,859 | |
| 1,315,585,859 | |
| 1,227,285,859 | |
| 1,138,985,859 |